甲福明对他类药物相关肌肉病的风险的影响在患有失脂症的患者中
Keunhyeong Bak1, Suhyeon Moon1, Minjung Ko1
1College of Pharmacy, Ajou University, Suwon, Republic of Korea.
Pharmacology research & perspectives
|July 7, 2023
概括
添加美特福尔来治疗失脂症患者的他类药物可能会降低肌肉病的风险. 这项研究发现,与仅使用他类药物相比,甲福明的药物治疗与肌肉毒性降低有关,这表明它具有保护作用.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 心血管医学 心血管医学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 在有代谢障碍的患者中,服用他类药物和抗糖尿病药物的联合治疗是常见的.
- 以前的研究表明,由于抗糖尿病药物和他类药物之间的药物相互作用,肌肉毒性可能会增加.
- 了解这些相互作用对于患者安全至关重要.
研究的目的:
- 为了研究甲型胺对已经接受他类药物治疗的失脂症患者肌肉病风险的影响.
- 为了比较使用他类药物与甲福明相结合的患者与单独使用他类药物的患者之间的肌肉病风险.
主要方法:
- 使用韩国国家医疗保险数据进行的回顾性队列研究.
- 倾向性得分匹配被用来创建可比的类他 + 甲胺使用者和仅使用类他的用户群体.
- 计算了危险比率 (HR) 和95%置信区间 (CI) 来评估肌肉病风险.
主要成果:
- 这项研究包括4092名病人在他类药物+甲福林组和8161名病人在仅服用他类药物的组,经过倾向分数匹配后.
- 与他类药物同时使用甲福林与肌肉病的风险降低有关 (调整HR为0.84;95%CI为0.71-0.99).
- 亚组和分层分析没有显示特定的他类药物剂或患者因素与肌肉病风险之间的显著关联.
结论:
- 在接受他类药物治疗的失脂症患者中,美特福明的治疗与肌肉病的风险降低有关.
- 甲胺可能提供保护性作用,防止他类药物诱导的肌肉毒性.
- 这些发现对治疗脱脂症和需要联合治疗的代谢障碍患者有意义.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
702
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
702
Oral Hypoglycemic Agents: Biguanides and Glitazones
238
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
238
Overview of Lipid Metabolism
1.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.8K
Dipeptidyl Peptidase 4 Inhibitors
214
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
214
Atherosclerosis III: Management
13
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
13
Cholesterol: Significance and Regulation
600
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
600


